Home > PJ (current issue) > News Feature | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7371 p476
15 October 2005

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

News feature

Reconfiguration of primary care trusts: what does it all mean for pharmacy?

This week, strategic health authorities had to submit proposals to the Department of Health on how primary care trusts in England should be reconfigured. How will pharmacy fit in with the new primary care structure and the move towards practice-based commissioning? Dawn Connelly (on the staff of The Journal) investigates


Criteria for PCT reconfiguration proposals

“Commissioning a patient-led NHS” specifies that proposals for primary care trust reconfiguration will be expected to consider practice, PCT and strategic health authority functions to deliver a fit for purpose health system with an effective and objective commissioning function able to deliver high quality care and value for money alongside the improvement of health promotion and protection.

Proposals will be assessed against the following criteria of the PCT’s ability to:

· Secure high quality, safe services

· Improve health and reduce inequalities

· Improve the engagement of GPs and roll-out of practice-based commissioning with demonstrable practice support

· Improve public involvement

· Improve commissioning and effective use of resources

· Manage financial balance and risk

· Improve co-ordination with social services through greater congruence of PCT and local government boundaries

· Deliver at least 15 per cent reduction in management and administrative costs

The rapid reconfiguration of primary care trusts has raised concerns for some health care professionals. The Department of Health document “Commissioning a patient-led NHS”, published this summer (PJ, 6 August, p156), revealed that primary care trusts could be cut by as much as 50 per cent and practice-based commissioning is to be implemented by the end of 2006 — two years earlier than initially planned.

For the past few years, community pharmacists have been encouraged to foster close working relationships with their PCTs so as to be in a better position when it comes to planning and bidding for enhanced services. With the move to universal practice-based commissioning, will these efforts have been wasted?

John Carr, a practice pharmacist and chairman of the professional executive committee at East Staffordshire PCT, is concerned about the direction things are taking. “Pharmacy has had a lot of benefits out of being involved and working closely with PCTs and I don’t know how that is going to happen easily in the future,” he says. He is worried that professional executive committees may become redundant. “In none of the proposals in our part of the world has there been any mention of clinical engagement. There has been no mention of whether PECs will continue to be in place for these new PCTs that are being created.” He fears that pharmacists may find it hard to establish a place on a large PEC in a new PCT — if one exists.

Brian Jolley, a pharmacist and PEC chairman at Waveney PCT, agrees. “It is hard to see how a PEC would fit into these new structures — would they need a PEC if [commissioning] is being run by practices, which are being managed by GPs,” he asks.

However, a DoH document “Practice-based commissioning — engaging practices in commissioning”, published in October 2004, indicated that PECs should play a strategic role in commissioning services. It states: “At the start of each financial period, practices or localities should draw up an agreement for how they intend to use any efficiency gains. The PEC will make a recommendation on this proposal to the PCT board.”

It goes on to list things that PECs may wish to consider when making their recommendations, including “that practices have the agreement of community matrons, district nurses, health visitors, allied health professionals and school nurses when making commissioning decisions for patients who are also the responsibility of other primary care practitioners.”

Practice-based commissioning

Practice-based commissioning transfers the responsibility, and the budget, for commissioning services from PCTs to individual GP practices or to groups of practices working together (localities). The PCT acts as an agent to undertake any required procurement and administrative tasks to underpin these processes and will be responsible for placing or managing contracts.

It is the complete change of the function of PCTs that concerns Mr Jolley. “My worry is about the challenge of practice-based commissioning and the fact that, in some areas, enhanced budgets could be given to practice-based commissioning consortia.” He argues that since pharmacists will be bidding for enhanced services commissioned by practices, they need to be involved in negotiations for the set-up of these services. “Guidance issued on practice-based commissioning so far is not clear on what happens with dentistry and pharmacy,” he says. “My view is that practice-based commissioning is going to be the biggest challenge for pharmacy. Pharmacists will need to have a flexible approach to providing new services in order to survive.”

Mr Carr is less optimistic. “Moving in this direction, I think, is a serious downturn for the closeness of pharmacists’ working relationships with the NHS, which is a pity after what has been quite a fruitful association in the past four years,” he concludes.

He believes that the only way pharmacists could have clinical involvement in the commissioning process is for practice-based commissioning localities to have a pharmacist as a member of a commissioning consortia board.

Opportunities

Barbara Parsons, head of pharmacy practice at the Pharmaceutical Services Negotiating Committee, believes the restructuring of primary care services offers opportunities for pharmacists. “It is not just a case of practice-based commissioning only being used to commission GP services. It is also a case of community pharmacists being able to look at the wider agenda and fitting in with the fact that all these services are up for grabs,” she says.

She also highlights the additional opportunities for pharmacists in the new general medical and personal medical services contracts: “If you want to provide a phlebotomy service or a vaccination service there is now also the possibility of becoming an alternative medical service provider.” Ms Parsons points out that, with the Government trying to balance payment by results and to move selected secondary care services into primary care, GPs will not be able to do it all.

The PSNC has produced an LPC Briefing on practice-based commissioning, which is available on its website or as a PDF (100K). It also hopes to publish guidance for community pharmacists on practice-based commissioning before the end of the year.

Next steps

The deadline for strategic health authorities to submit proposals on the reconfiguration of PCTs to the DoH is 15 October. The DoH will consider these proposals and issue its decision at the end of November. If agreed, a public consultation on the proposed administrative changes to PCTs will then take place.

Proposals on the provider aspect of PCTs will not be considered by the DoH until after the publication of the White Paper on health outside hospitals due at the turn of the year.
PCT reconfiguration is expected to be complete by October 2006, with changes to PCT service provision to be completed by the end of 2008.

Back to Top


©The Pharmaceutical Journal